Trinity Biotech (TRIB) Depreciation & Amortization - Total (2014 - 2024)

Trinity Biotech has disclosed Depreciation & Amortization - Total across 5 years of filings, most recently posting $260.0 for Q3 2024.

• In Q3 2024, Depreciation & Amortization - Total rose 50.29% year-over-year to $260.0; the TTM figure through Sep 2024 stood at $532.0 (down 99.98% YoY), while the FY2016 annual figure was $2.9 million, up 0.6% from the prior year.
• Depreciation & Amortization - Total came in at $260.0 for Q3 2024 at Trinity Biotech, up from -$65.0 in the prior quarter.
• In the past five years, Depreciation & Amortization - Total ranged from a high of $351.0 in Q1 2023 to a low of -$65.0 in Q2 2024.